Surgical Science Sweden AB
STO:SUS
Intrinsic Value
The intrinsic value of one SUS stock under the Base Case scenario is 183.23 SEK. Compared to the current market price of 125 SEK, Surgical Science Sweden AB is Undervalued by 32%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Surgical Science Sweden AB
Fundamental Analysis

Revenue & Expenses Breakdown
Surgical Science Sweden AB
Balance Sheet Decomposition
Surgical Science Sweden AB
Current Assets | 1.4B |
Cash & Short-Term Investments | 968.2m |
Receivables | 180.4m |
Other Current Assets | 277.5m |
Non-Current Assets | 4.1B |
Long-Term Investments | 8m |
PP&E | 101.5m |
Intangibles | 3.9B |
Other Non-Current Assets | 16.3m |
Free Cash Flow Analysis
Surgical Science Sweden AB
SEK | |
Free Cash Flow | SEK |
Earnings Waterfall
Surgical Science Sweden AB
Revenue
|
884.1m
SEK
|
Cost of Revenue
|
-286.2m
SEK
|
Gross Profit
|
597.9m
SEK
|
Operating Expenses
|
-453.6m
SEK
|
Operating Income
|
144.3m
SEK
|
Other Expenses
|
-12.7m
SEK
|
Net Income
|
131.6m
SEK
|
SUS Profitability Score
Profitability Due Diligence
Surgical Science Sweden AB's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
Score
Surgical Science Sweden AB's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
SUS Solvency Score
Solvency Due Diligence
Surgical Science Sweden AB's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
Surgical Science Sweden AB's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SUS Price Targets Summary
Surgical Science Sweden AB
According to Wall Street analysts, the average 1-year price target for SUS is 198.49 SEK with a low forecast of 181.8 SEK and a high forecast of 225.75 SEK.
Dividends
Current shareholder yield for SUS is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one SUS stock under the Base Case scenario is 183.23 SEK.
Compared to the current market price of 125 SEK, Surgical Science Sweden AB is Undervalued by 32%.